Article

On the Generation of Novel Ligands for SARS-CoV-2 Protease and ACE2 Receptor via Constrained Graph Variational Autoencoders

2020-03-24

Abstract excerpt

SARS-CoV-2 has no known vaccine nor any effective treatment that has been released for clinical trials yet. This has ultimately paved the way for novel drug discovery approaches since although there are multiple efforts focused on drug repurposing of clinically-approved drugs for SARS-CoV-2, it is also worth considering that these existing drugs can be surpassed in effectivity by novel ones. This research focuses...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f8322d06-379b-577b-9e39-2af3cd482c68
DOI: 10.26434/chemrxiv.12011157.v3

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

On the Generation of Novel Ligands for SARS-CoV-2 Protease and ACE2 Receptor via Constrained Graph Variational AutoencodersDOI 10.26434/chemrxiv.12011157.v3Read

Novel graph attention autoencoder framework with multilayered validation identifies drug repurposing candidates for COVID-19 treatmentSemantic proximity Read

A Deep Learning Proteomic Scale Approach for Drug DesignSemantic proximity Read

Multilayered validation of graph attention autoencoder–derived drug repurposing candidates for COVID-19Semantic proximity Read

A Novel de novo Design Study of Potent SARS-CoV-2 Main Protease Inhibitors Based on Reinforcement Learning and Molecular DockingSemantic proximity Read

De Novo Design and Bioactivity Prediction of SARS-CoV-2 Main Protease Inhibitors Using ULMFitSemantic proximity Read

Artificial neural network-based study predicts GS-441524 as a potential inhibitor of SARS COV-2 activator protein furin: A polypharmacology approachSemantic proximity Read

New Potential Drug Candidates Against SARS-CoV-2 Using Generative ModelSemantic proximity Read

Improved And Optimized Drug Repurposing For The SARS-CoV-2 PandemicSemantic proximity Read

Discovery of novel quinoline papain-like protease inhibitors for COVID-19 through topology constrained molecular generative modelSemantic proximity Read

Analysis of protein-ligand interactions of SARS-CoV-2 against selective drug using deep neural networksSemantic proximity Read

Repurposing Drugs for COVID-19 by Graph Convolutional NetworkSemantic proximity Read

Profiling Molecular Simulations of SARS-CoV-2 Main Protease (Mpro) Binding to Repurposed Drugs Using Neural Network Force FieldsSemantic proximity Read